Gene Increases Risk of Death, Heart Attack, or Stroke
Results from the International Verapamil SR-Trandolapril study (INVEST-GENES) show that hypertensive patients who carry the tryptophan version of the alpha-adducin gene have a 43 percent higher risk of death, heart attack or stroke. Up to 40 percent of the general population may carry at least one copy of the tryptophan variant.
Dr. Julie Johnson, director of the UF Center for Pharmacogenomics, said:
One of the goals of our research is to identify the genes that are related to patient-to-patient differences in response to medications. Personalizing drugs based on genetic makeup instead of taking a trial-and-error approach could lead to safer, more effective treatments for individual patients.
EurekAlert, November 17, 2005
Related Stories
POSTED IN: General Genetics and Health
.gif)
1 opinion for Gene Increases Risk of Death, Heart Attack, or Stroke
rhonda
Jan 8, 2008 at 7:21 pm
Thanks for the notice. If you could include information, such as how one may test it they have this variation, it would be helpful.
Have an opinion? Leave a comment: